Study Asserts that FDA’s Inefficiencies Delay Patient Access and Raise Costs of New Medical Technologies
Abstract:President and CEO of the Advanced Medical Technology Association (AdvaMed), Stephen J. Ubl, released a statement on November 18, 2010, on a new study that evaluates the impact of device regulation on continued medical innovation.
Trending Compliance Trainings
Excel Spreadsheets; Ensuring Data Integrity and 21 CFR Part 11 Compliance
By - David Nettleton
On Demand Access Anytime
By - David Nettleton
On Demand Access Anytime
Water System Investigation "How-To's" and Example Case Studies
By - T.C Soli
On Demand Access Anytime
By - T.C Soli
On Demand Access Anytime
Solutions for Addressing Fungal and Bacterial Spore Outbreaks in Pharmaceutical, Biotech, and Medical Device Operations
By - Jim Polarine
On Demand Access Anytime
By - Jim Polarine
On Demand Access Anytime
How to Achieve a Compliant and Effective Cleanroom Design and Facility Validation
By - Charity Ogunsanya
On Demand Access Anytime
By - Charity Ogunsanya
On Demand Access Anytime
FDA Compliance and Clinical Trial Computer System Validation
By - Carolyn Troiano
On Demand Access Anytime
By - Carolyn Troiano
On Demand Access Anytime
You Recently Viewed
